Skip to content
OpenCapital
Get started

OrthoPediatrics KIDS Convertible Debt (Non-Current)

Convertible Debt (Non-Current) at other companies

Richtech Robotics Inc. logo
Richtech Robotics Inc.RR
$118K+15.7%
Celcuity logo
CelcuityCELC
$195.57M—
Wolfspeed logo
WolfspeedWOLF
$798.3M-73.8%
Esperion Therapeutics logo
Esperion TherapeuticsESPR
$97.39M+0.5%
Plug Power logo
Plug PowerPLUG
$502.77M+97.0%
Ur-Energy logo
Ur-EnergyURG
$67.56M—

Other financials

Income statement

See full
Revenue$59.4M+13.3%
Gross profit$43.4M+13.4%
Operating income-$8.3M+24.1%
Net income-$10.7M-0.3%
EPS (diluted)-$0.45+2.2%

Balance sheet

See full
Cash & equivalents$14.2M-59.8%
Total debt$5.4M+271%
Total equity$338.7M-2.4%
Total assets$502.2M+6.8%

Cash flow

See full
Operating cash flow-$3.3M+20.9%
CapEx$1.8M-58.4%
Free cash flow-$5.0M+39.8%

Valuation

See full
Market cap$503.94M+0.3%
Enterprise value$495.11M+5.7%
P/S2.1×-0.3×

Profitability

See full
Gross margin73.1%+0.3pp
Operating margin-15%-1.6pp
Net margin-16.3%-2.1pp
FCF margin-12.9%-4.3pp

Returns & leverage

See full
Return on equity-11.6%+0.2pp
Debt / equity0×0.0×
Current ratio5.2×-1.0×

Where this comes from

Reported directly by OrthoPediatrics in its filing.

Tagged under the XBRL concept us-gaap:ConvertibleLongTermNotesPayable.

The official record: OrthoPediatrics’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about OrthoPediatrics's convertible debt (non-current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OrthoPediatrics's convertible debt (non-current)?
OrthoPediatrics (KIDS) reported convertible debt (non-current) of $48.64M in Q1 2026.
How has OrthoPediatrics's convertible debt (non-current) changed year-over-year?
OrthoPediatrics's convertible debt (non-current) increased by 1.3% year-over-year, from $48.04M to $48.64M.
What does convertible debt (non-current) mean?
This represents the principal amount of debt obligations that can be converted into equity and are due beyond a one-year timeframe. It serves as a hybrid financing instrument that provides capital while potentially diluting future shareholder ownership upon conversion. Analyzing this metric helps investors understand the company's long-term leverage profile and potential future equity dilution.